API Holdings Ltd- PharmEasy Unlisted Shares

Buy PharmEasy Unlisted Shares

 About Company:

They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. They operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages
A. providing digital tools and information on illness and wellness,
B. offering teleconsultation,
C. offering diagnostics and radiology tests, and
D. delivering treatment protocols including products and devices.

Their custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.
These capabilities enable them to provide each stakeholder in the healthcare value-chain, viz.:
(a) channel (wholesalers, retailers and chemists / institutions),
(b) consultants (and hospitals), diagnostic and radiology labs,
(c) consumers, and
(d) companies (pharmaceutical, nutraceutical, medical devices)
with the technology tools and capabilities to solve their challenges, while also enabling them to benefit from an interconnected network. At the same time, they also enable them to build a scaled presence, allowing their platform to reach a wide base of stakeholders across the length and breadth of this country. Their businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing them the ability to provide access in an affordable manner to the common man. Their platforms have scaled across urban, semi-urban and rural India, with an ability to serve people across income groups and geographies.

pharmeasy unlisted sharesSource: PharmEasy IPO DRHP
pharmeasy unlisted sharesSource: PharmEasy IPO DRHP
pharmeasy unlisted shares pharmeasy unlisted sharesSource: PharmEasy IPO DRHP

Pharmeasy:
PharmEasy is a consumer healthcare “super app”.
PharmEasy is a consumer healthcare “super app” that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultations thereby serving their healthcare needs.
25 Million+Total Users
8.8 million+Total Orders
2.4 million+Transacting Customers

Services:
Order Medicines
Healthcare Products
Diagnostic Tests

pharmeasy unlisted sharesSource: PharmEasy IPO DRHP

 PharmEasy Unlisted Shares Details

Unlisted Share Details
NameAPI Holdings Limited Unlisted Shares
Alias NamePharmEasy
Face Value₹ 1
ISIN CodeINE0DJ201029
Unlisted Share Price₹ 47 Per Share
Lot Size500 Shares
PANAASCA1201E

 API Holdings Limited – Financials

Financial in Millions unless specifically mentioned
Particulars2019-202020-21
Revenues from Operations6675.4223352.69
Total Income7374.4823606.62
Total Expenses10844.0429809.28
Profit/(Loss) before tax(3469.56)(6202.66)
Profit/(Loss) after tax for the period(3352.79)(6413.36)

 PharmEasy Unlisted Shares Price

*Rates mentioned in the chart are indicative.

 PharmEasy Unlisted Shares – Valuation (Market Capitalisation)

Total Number of Outstanding Shares: 6,098,109,930 (As per PharmEasy IPO DRHP)

Market Cap Scenarios:

At 45 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 27,400 crores.

This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.

At 50 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 30,490 crores.

This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.

At 55 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs. 33,540 crores.

This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.

At 60 Rs/Share, PharmEasy Unlisted Shares values the company at approx. Rs.36,590 crores.

This are just pre-defined scenarios, since the market cap is variable to price, you can calculate the latest market cap based on the ongoing rates of pharmeasy unlisted shares.

 API Holdings Limited – Key Shareholding

Source: PharmEasy IPO DRHP
Other Shareholders includes key shareholders & public

 API Holdings Limited – PharmEasy IPO DRHP

 API Holdings Limited – News

 FAQ for PharmEasy Unlisted Shares

How to buy PharmEasy Unlisted Shares?

  1. Process of Buying PharmEasy Unlisted Shares
  2. Get connected with us and inquire for the PharmEasy Unlisted Shares
  3. We will quote the current prevailing market rates of the shares (Subject to availability)
  4. If you agree on the rate and quantity, we will send our bank details. (Please note, we accept payment only through bank)
  5. Buyer transfers the fund in our bank account and buyer also need to send their demat details (for initiating share transfer process)
  6. Post receiving funds and demat details, we initiate transfer of PharmEasy unlisted shares. The shares usually gets transferred on same/next working day in your demat account
  7. For detailed buying process, refer here

What is the minimum lot size for buying PharmEasy Unlisted Shares?

The minimum lot size for investing in PharmEasy Unlisted Shares is 200 Shares

What is the lock-in period for PharmEasy Unlisted Shares?

The Lock-in period for PharmEasy Unlisted Shares will be Six Months. The Lock-in period starts from the date of IPO allotment.(According to DRHP)

Is buying PharmEasy Unlisted Shares Legal?

Yes, buying PharmEasy Unlisted Shares is completely legal.

How to check price of PharmEasy Unlisted Shares?

You can regularly check the updated price of PharmEasy Unlisted Shares at our Website and on our Telegram Channel

When can we expect IPO of PharmEasy (API Holdings Limited)?

The IPO of PharmEasy (API Holdings Limited) can be expected in very short term. The company has already filed its DRHP with SEBI.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound